Comparison of efficacy and safety of empagliflozin vs linagliptin added to premixed insulin in patients with uncontrolled type 2 diabetes: A randomized, open-label study.

Liu, S-C; Lee, C-C; Chuang, S-M; Sun, F-J; Zeng, Y-H

Liu, S-C; Lee, C-C; Chuang, S-M; Sun, F-J; Zeng, Y-H.

Afiliação

Liu SC; Division of Endocrinology and Metabolism, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan; Department of Medicine, MacKay Medical College, New Taipei City, Taiwan.
Lee CC; Division of Endocrinology and Metabolism, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan; Department of Medicine, MacKay Medical College, New Taipei City, Taiwan.
Chuang SM; Division of Endocrinology and Metabolism, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan; MacKay Junior College of Medicine, Nursing and Management, Taipei, Taiwan.
Sun FJ; MacKay Junior College of Medicine, Nursing and Management, Taipei, Taiwan; Department of Medical Research, MacKay Memorial Hospital, Taipei, Taiwan; Institute of Biomedical Informatics, National Yang Ming University, Taipei, Taiwan.
Zeng YH; Division of Endocrinology and Metabolism, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan; Department of Medicine, MacKay Medical College, New Taipei City, Taiwan; Institute of Public Health, National Yang Ming University, Taipei, Taiwan. Electronic address: starrydouchain@

Diabetes Metab ; 47(3): 101184, 2021 05.

Article em En | MEDLINE | ID: mdl-32827752

Assuntos

Compostos Benzidrílicos; Diabetes Mellitus Tipo 2; Glucosídeos; Insulina; Linagliptina; Compostos Benzidrílicos/efeitos adversos; Diabetes Mellitus Tipo 2/tratamento farmacológico; Inibidores da Dipeptidil Peptidase IV/efeitos adversos; Quimioterapia Combinada/efeitos adversos; Glucosídeos/efeitos adversos; Humanos; Hipoglicemiantes/administração & dosagem; Insulina/administração & dosagem; Linagliptina/efeitos adversos; Inibidores do Transportador 2 de Sódio-Glicose/efeitos adversos; Resultado do Tratamento

Palavras-chave

DPP4 inhibitor; Insulin; SGLT2 inhibitor; Type 2 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Diabetes Mellitus Tipo 2 / Linagliptina / Glucosídeos / Insulina Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google